Leading science, pioneering therapies


  1. Stem cell study paves the way for patient therapies

    Nov 26

    Stem cells that have been specifically developed for use as clinical therapies are fit for use in patients, an independent study of their genetic make-up suggests. The research – which focused on human embryonic stem cells – paves the way for clinical trials of cell therapies to treat conditions such as Parkinson’s disease, age-related degeneration of the eyes and spinal cord injury.

  2. Liver cell therapies closer as study reveals key to mass production

    Nov 25

    Stem cell scientists have made a key find that aids the quest to produce therapies for patients with liver damage. They have developed a new technique for growing liver cells from stem cells that is cost-effective and could be adapted for mass production of clinical grade cells.

  3. Skin scent offers Parkinson’s hope

    Oct 22

    Researchers are to investigate whether Parkinson’s disease can be diagnosed from skin swabs.

  4. PhD student Alison McGarvey wins Wilmut Prize

    Oct 5

    The MRC Centre for Regenerative Medicine (CRM) acknowledges the hard work of our PhD students and the contributions these students make towards the CRM and to the scientific community.

  5. New 'Tissue Repair' PhD programme

    Sep 25

    The University of Edinburgh has been awarded a new 4yr PhD programme by the Wellcome Trust.

  6. CRM welcomes 18 new PhD students

    Sep 18

    The MRC Centre for Regenerative Medicine (CRM) offers an integrated and structured postgraduate PhD training programme to provide high-level training in theoretical and practical aspects of stem cell biology and regenerative medicine.

  7. Immunity study signals new ways to treat liver failure

    Sep 9

    Patients with liver failure could benefit from a treatment that helps the immune system to combat infections linked to the condition, research suggests.

  8. Liver regrown from stem cells

    Jul 20

    Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.

  9. Golf stars in fundraising drive for multiple sclerosis research

    Jun 11

    Golf champions from the Ladies European Tour have teamed up with amateur players to raise funds for multiple sclerosis (MS) research.

  10. Fundraising for research at the Edinburgh Marathon Festival (EMF)

    Jun 1

    Jenny Thoms, a runner with close personal links to the MRC Centre for Regenerative Medicine (CRM), ran the full Edinburgh marathon at the weekend, while her auntie, Marjorie Thoms, ran the half-marathon, both raising funds for CRM and supporting our vital research into degenerative diseases.

  11. £2m funding for Edinburgh Centre for MS Research

    Apr 27

    The MS Society today announced it is investing a further £2 million into a world-class MS research hub known as the Edinburgh Centre for MS Research.

  12. Transcription factors target tightly packed DNA to initiate reprogramming

    Apr 16

    Tremendous advances in the field of stem cells have made it possible to convert cells into other types using transcription-factors-mediated reprogramming methods in the laboratory.

  13. £10.7M funding for new Centre for Tissue Regeneration and Repair

    Mar 25

    A £25.7 million funding boost will advance biological research and aid the quest for new therapies to treat damaged tissues. The investment by the UK Government will enable the University of Edinburgh to establish a new Centre for Tissue Repair (£10.7M) and create laboratory space for 350 biologists (£14.9M).

  14. Bile duct cancer study may pave way for new treatments

    Feb 18

    Patients with bile duct cancer could be helped by a new class of experimental drug, a study has shown.

  15. University of Edinburgh and Genzyme collaboration aims to reduce neurodegeneration in MS

    Jan 12

    University of Edinburgh scientists are set to work with leading biotechnology company Genzyme, a Sanofi company, to carry out drug discovery research that could reduce neuron damage in the brain.

  16. CRM researchers contribute to excellent REF 2014 results

    Dec 18

    The 2014 UK Research Excellence Framework (REF) results were announced earlier today.

  17. Cell therapy trial offers new hope to liver disease patients

    Nov 18

    Liver disease patients could be helped by a new cell therapy to treat the condition.

  18. PhD student Tyson Ruetz wins Wilmut Prize

    Nov 18

    The MRC Centre for Regenerative Medicine (CRM) acknowledges the hard work of our PhD students and the contributions these students make towards the CRM and to the scientific community.

  19. Protein called Cited2 is an essential regulator of embryonic stem cell functions

    Nov 13

    Many researchers worldwide are trying to unravel how embryonic stem (ES) cells are controlled. A better understanding of this process is an essential step in developing treatments using stem cells.

  20. Researchers grow ‘seed’ of spinal cord tissue in a dish

    Aug 26

    Medical Research Council (MRC) scientists have for the first time managed to turn stem cells into the specialised cells that go on to form spinal cord, muscle and bone tissue in the growing embryo. Their discovery could lead to a new way of studying degenerative conditions such as spinal muscular atrophy, which affects the nerve cells in the spinal column, and may pave the way for future treatments for this and other neuromuscular conditions.